Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
PCI Biotech Holding ASA banner

PCI Biotech Holding ASA
OSE:PCIB

Watchlist Manager
PCI Biotech Holding ASA Logo
PCI Biotech Holding ASA
OSE:PCIB
Watchlist
Price: 0.185 NOK -10.63% Market Closed
Market Cap: kr6.9m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

PCIB Price Targets Summary
PCI Biotech Holding ASA

There are no price targets for PCIB.
PCIB Lowest Forecast
Wall Street Target
Not Available
PCIB Average Forecast
Wall Street Target
Not Available
PCIB Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
PCI Biotech Holding ASA Competitors:
Price Targets
S
STG
Strip Tinning Holdings PLC
127% Upside
WINA
Winmark Corp
25% Upside
V
VERK
Verkkokauppa.com Oyj
20% Upside
TCPC
BlackRock TCP Capital Corp
36% Upside
S
STG
Strip Tinning Holdings PLC
127% Upside
WINA
Winmark Corp
25% Upside
V
VERK
Verkkokauppa.com Oyj
20% Upside
TCPC
BlackRock TCP Capital Corp
36% Upside
S
SANA
Sana Biotechnology Inc
114% Upside

Revenue
Forecast

-1% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
-1% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

For the last 13 years the compound annual growth rate for PCI Biotech Holding ASA's revenue is -1%. The projected CAGR for the next 3 years is 9%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss

What are analyst estimates?

See Also

Summary
PCIB intrinsic value, competitors valuation, and company profile.
DCF Valuation
PCIB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PCIB stock valuation using valuation multiples.
Wall Street Estimates
PCIB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PCIB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PCIB's stock price target?
Not Available

PCIB doesn't have any price targets made by Wall Street professionals.

What is PCI Biotech Holding ASA's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for PCI Biotech Holding ASA's revenue is -1%. The projected CAGR for the next 3 years is 9%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 315,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.